Seeking Alpha

Ironwood Pharmaceuticals (IRWD +4.7%) trades up after Credit Suisse raises the shares to...

Ironwood Pharmaceuticals (IRWD +4.7%) trades up after Credit Suisse raises the shares to Outperform and raised its price target to $24 from $15. The firm says IRWD is poised to see strong demand for its IBS drug Linzess, based on a survey of 100 physicians.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|